**Hims & Hers Health, Inc. Reports Fiscal Year 2025 Results**
Hims & Hers Health, Inc., a telehealth platform focused on providing personalized health and wellness solutions, announced its financial results for the year ended December 31, 2025. The company reported total revenue of $2.348 billion, a 59% increase compared to $1.477 billion in 2024. This growth was primarily driven by a 53% increase in United States revenue, reaching $2.214 billion, and a substantial 399% increase in Rest of the World revenue, totaling $134 million. The company attributed the revenue increase to the expansion of personalized offerings, the growth of the Hers brand, and the geographic expansion resulting from recent acquisitions.
The company achieved a net income of $128.4 million for 2025, a slight increase from $126 million in 2024. Adjusted EBITDA for the year was $318 million, representing 14% of revenue, compared to $176.9 million in the previous year, which was 12% of revenue. Key operational metrics included a subscriber base of 2.511 million at the end of 2025, a 13% increase from 2.229 million in 2024. Monthly Revenue per Average Subscriber increased by 28% to $83, while Monthly Online Revenue per Average Subscriber increased by 27% to $81.
Strategic developments during the year included the acquisitions of Zava, a digital health platform in the United Kingdom and European Union, and Medici, a digital health platform in Canada. These acquisitions expanded the company's geographic reach and service offerings. In February 2026, Hims & Hers announced a definitive agreement to acquire Eucalyptus, an Australia-based digital health company, for up to $1.15 billion, further expanding its international presence. The company also launched comprehensive laboratory testing services and expanded its offerings to include testosterone, menopause, and perimenopause support.
Operational developments included the expansion of the company's facilities, including licensed 503A and 503B pharmacies, a peptide manufacturing facility, and a laboratory testing services facility. As of December 31, 2025, the company employed 2,442 individuals and contracted with 1,586 medical providers in the United States and approximately 30 licensed healthcare providers in Canada. Looking ahead, Hims & Hers plans to continue investing in growth, expanding its product and service offerings, and penetrating new sales channels and geographies. The company anticipates that revenue from personalized offerings will increasingly drive revenue growth in the future.
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a digital health platform providing personalized telehealth services, including virtual consultations, prescriptions, and wellness products for conditions like sexual health, dermatology, mental health, and weight management. Serving consumers in the U.S. and UK, it leverages proprietary technology, licensed provider networks, and pharmacy fulfillment to deliver accessible, affordable, and high-quality healthcare and wellness solutions through subscription-based models.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.